CELLPROTHERA
Dead / Cancelled — International registration cancelled — extension of protection cancelled (as of 01 Aug 2019)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 79076423
- Registration number
- 3980163
- Mark type
- Design + words
- Filed
- 31 Jul 2009
- Published for opposition
- 05 Apr 2011
- Registered
- 21 Jun 2011
- Attorney of record
- Jonathan Myers
Goods and services
- Class 005 — Pharmaceuticals: Biological preparations for cell cultures; cell culture media, namely, culture media for endothelial and myocardiac cells; culture media for cell growth for medical biotechnology, namely,culture media for growing and regenerating endothelial and myocardiac cells; biological reagents for molecular biology; chemical reagents for medical use for biological processes; carriers of culture media for medical use, namely, Iscove's modified Dulbecco's medium, used for rapidly proliferating high density cell cultures; cellular function activating agents, namely,cell growth factors, hematopoietic factors, serums, namely, human and animal serums for cell culture; antibodies, namely, monoclonal antibodies for detection and treatment of pathologies; all these products being for medical use
- Class 010 — Medical apparatus: Medical apparatus and instruments, namely, intravascular cell reinjection catheters; apparatus for human cell culture, namely, medical device for providing human cell culture diagnosis and treatment; cell analyzers for medical treatment and diagnostic use; medical device for production of human cell grafts, namely, medical device allowing in vitro stem cell expansion for therapeutic use; instruments for cell culture, namely, medical instruments used for cell culture diagnosis and treatment; medical device for human cell selection, namely, medical device for human cell immune selection used for diagnosis and treatment
- Class 042 — Scientific and technological services: Research and development of new products in the field of biotechnology; services for scientific analysis for medical purposes, namely, medical research laboratory services; development of new products for medical research for third parties
- Class 044 — Medical, beauty and agricultural services: Medical care and treatment; medical services for cell sampling and isolation, namely, leukapheresis medical treatment services; services for medical analysis relating to treating individuals, namely, behavior analysis for medical purposes; therapeutic treatment, namely, cell therapy for regenerative medicine
Owner
- CELLPROTHERA, FR
- CELLPROTHERA, FR
- CELLPROTHERA, FR
Prosecution history
- 30 May 2022 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 29 Oct 2021 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 04 Sept 2021 — NOTIFICATION PROCESSED BY IB
- 29 Aug 2020 — REFUSAL PROCESSED BY IB
- 21 Feb 2020 — NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
- 21 Feb 2020 — DEATH OF INTERNATIONAL REGISTRATION
- 22 Aug 2019 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 01 Aug 2019 — NEW REPRESENTATIVE AT IB RECEIVED
- 14 Dec 2018 — TOTAL INVALIDATION PROCESSED BY THE IB
- 27 Sept 2018 — TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 27 Sept 2018 — INVALIDATION PROCESSED
- 26 Sept 2018 — TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
- 26 Jan 2018 — CANCELLED SECTION 71
- 14 May 2013 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 17 Nov 2011 — FINAL DISPOSITION NOTICE SENT TO IB